<p>CD4+ T cell counts (in black) and plasma HIV-1 RNA viral loads (in blue) during the follow-up after PHI diagnosis in the 14 PTCs included in the study. The detectable viral loads after treatment interruption are indicated in red. The gray areas represent the periods during which the patients received cART.</p
Potent antiretroviral therapy has dramatically improved the prognosis of patients infected with HIV-...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
<p>Kaplan-Meier curve of the probability for patients included in the FHDH between 1997 and 2011 to ...
Early treatment of acute HIV infection with highly active antiretroviral therapy, followed by superv...
Background: Transient episodes of HIV type-1 viraemia are frequently observed in patients on suppres...
International audienceCombination antiretroviral therapy (cART) reduces HIV-associated morbidities a...
<div><p>Combination antiretroviral therapy (cART) reduces HIV-associated morbidities and mortalities...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
Objective: To investigate immunologic, virologic, and clinical consequences of episodes of transient...
We studied the dynamics of CD4 cell counts after the interruption of virologically successful highly...
The impact of Structured Treatment Interruption (STI) in peripheral blood mononuclear cell (PBMC) pr...
Background Long-term treatment of primary HIV-1 infection (PHI) may allow the immune reconstitution ...
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after ...
To provide insight into the dynamics and source of residual viremia in human immunodeficiency virus ...
Potent antiretroviral therapy has dramatically improved the prognosis of patients infected with HIV-...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...
<p>Kaplan-Meier curve of the probability for patients included in the FHDH between 1997 and 2011 to ...
Early treatment of acute HIV infection with highly active antiretroviral therapy, followed by superv...
Background: Transient episodes of HIV type-1 viraemia are frequently observed in patients on suppres...
International audienceCombination antiretroviral therapy (cART) reduces HIV-associated morbidities a...
<div><p>Combination antiretroviral therapy (cART) reduces HIV-associated morbidities and mortalities...
BACKGROUND: CD4+ T-cell recovery in patients with continuous suppression of plasma HIV-1 viral load ...
Objective: To investigate immunologic, virologic, and clinical consequences of episodes of transient...
We studied the dynamics of CD4 cell counts after the interruption of virologically successful highly...
The impact of Structured Treatment Interruption (STI) in peripheral blood mononuclear cell (PBMC) pr...
Background Long-term treatment of primary HIV-1 infection (PHI) may allow the immune reconstitution ...
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia after ...
To provide insight into the dynamics and source of residual viremia in human immunodeficiency virus ...
Potent antiretroviral therapy has dramatically improved the prognosis of patients infected with HIV-...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
Background: Few individuals commencing antiretroviral therapy (ART) in primary HIV infection (PHI) m...